CA2343602A1 - Est et proteines humaines codees - Google Patents

Est et proteines humaines codees Download PDF

Info

Publication number
CA2343602A1
CA2343602A1 CA002343602A CA2343602A CA2343602A1 CA 2343602 A1 CA2343602 A1 CA 2343602A1 CA 002343602 A CA002343602 A CA 002343602A CA 2343602 A CA2343602 A CA 2343602A CA 2343602 A1 CA2343602 A1 CA 2343602A1
Authority
CA
Canada
Prior art keywords
nos
seq
sequences
sequence
est
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002343602A
Other languages
English (en)
Inventor
Stephane Bejanin
Hiroaki Tanaka
Jean-Baptiste Dumas Milne Edwards
Severin Jobert
Jean-Yves Giordano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of CA2343602A1 publication Critical patent/CA2343602A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
CA002343602A 2000-04-18 2001-04-17 Est et proteines humaines codees Abandoned CA2343602A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19787300P 2000-04-18 2000-04-18
US60/197,873 2000-04-18

Publications (1)

Publication Number Publication Date
CA2343602A1 true CA2343602A1 (fr) 2001-10-18

Family

ID=22731080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343602A Abandoned CA2343602A1 (fr) 2000-04-18 2001-04-17 Est et proteines humaines codees

Country Status (1)

Country Link
CA (1) CA2343602A1 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7365154B2 (en) * 2003-06-23 2008-04-29 Centocor, Inc. Peptides antagonistic to an anti-angiogenic antibody and uses therefor
US7713521B2 (en) 2005-08-12 2010-05-11 Schering Corporation MCP1 fusions
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
US9388215B2 (en) 2013-03-15 2016-07-12 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US9758807B2 (en) 2012-12-05 2017-09-12 SOLA Biosciences, LLC Protein expression enhancing polypeptides
WO2017173321A1 (fr) * 2016-03-31 2017-10-05 Neon Therapeutics, Inc. Néoantigènes et leurs procédés d'utilisation
WO2017182395A1 (fr) * 2016-04-21 2017-10-26 Immatics Biotechnologies Gmbh Immunothérapie contre le mélanome et d'autres cancers
CN110064045A (zh) * 2019-05-15 2019-07-30 苏州大学 微肽cip2a-bp在治疗癌症中的应用
US10435455B1 (en) 2016-04-21 2019-10-08 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
AU2021244056B2 (en) * 2020-03-27 2024-04-04 Onecuregen Co., Ltd. Composition comprising VGLL1 peptide for treatment of cancer
WO2024165674A1 (fr) * 2023-02-08 2024-08-15 Guard Therapeutics International AB Fragments peptidiques dérivés de alpha-1-microglobuline et leurs utilisations

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7365154B2 (en) * 2003-06-23 2008-04-29 Centocor, Inc. Peptides antagonistic to an anti-angiogenic antibody and uses therefor
US7713521B2 (en) 2005-08-12 2010-05-11 Schering Corporation MCP1 fusions
US7972591B2 (en) 2005-08-12 2011-07-05 Schering Corporation Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions
US8282914B2 (en) 2005-08-12 2012-10-09 Merck, Sharp & Dohme Corp. Method for treating atherosclerosis by administering human MCP1 fusions
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US9758807B2 (en) 2012-12-05 2017-09-12 SOLA Biosciences, LLC Protein expression enhancing polypeptides
AU2013355120B2 (en) * 2012-12-05 2017-11-09 Sola Biosciences Llc Protein expression enhancing polypeptides
US9388215B2 (en) 2013-03-15 2016-07-12 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US9738695B2 (en) 2013-03-15 2017-08-22 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US10899815B2 (en) 2013-03-15 2021-01-26 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
WO2017173321A1 (fr) * 2016-03-31 2017-10-05 Neon Therapeutics, Inc. Néoantigènes et leurs procédés d'utilisation
US10519216B2 (en) 2016-04-21 2019-12-31 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10435455B1 (en) 2016-04-21 2019-10-08 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
WO2017182395A1 (fr) * 2016-04-21 2017-10-26 Immatics Biotechnologies Gmbh Immunothérapie contre le mélanome et d'autres cancers
US10364281B2 (en) 2016-04-21 2019-07-30 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10385110B2 (en) 2016-04-21 2019-08-20 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10385111B2 (en) 2016-04-21 2019-08-20 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10435454B2 (en) 2016-04-21 2019-10-08 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10035838B2 (en) 2016-04-21 2018-07-31 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10464991B2 (en) 2016-04-21 2019-11-05 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US9901629B2 (en) 2016-04-21 2018-02-27 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US10640547B2 (en) 2016-04-21 2020-05-05 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
CN110064045A (zh) * 2019-05-15 2019-07-30 苏州大学 微肽cip2a-bp在治疗癌症中的应用
CN110064045B (zh) * 2019-05-15 2022-12-23 苏州大学 微肽cip2a-bp在治疗癌症中的应用
AU2021244056B2 (en) * 2020-03-27 2024-04-04 Onecuregen Co., Ltd. Composition comprising VGLL1 peptide for treatment of cancer
WO2024165674A1 (fr) * 2023-02-08 2024-08-15 Guard Therapeutics International AB Fragments peptidiques dérivés de alpha-1-microglobuline et leurs utilisations

Similar Documents

Publication Publication Date Title
US7413875B2 (en) ESTs and encoded human proteins
US7235381B2 (en) Expressed sequence tags and encoded human proteins
US6936692B2 (en) Complementary DNAs
EP1033401A2 (fr) Marqueurs de séquence exprimées et protéines humaines codées
EP1037977B1 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
US20060223142A1 (en) Extended cDNAs for secreted proteins
US7393663B2 (en) Expressed sequence tags and encoded human proteins
US7056680B2 (en) Antibodies to claudin-50 polypeptide
EP1144444A2 (fr) Adn complementaires codant pour des proteines secretees avec des peptides signaux
WO1999006439A2 (fr) Est 5' pour proteines secretees exprimees dans l'endoderme
CA2343602A1 (fr) Est et proteines humaines codees
EP1541683A1 (fr) ESTs et leurs protéines codées humaines
AU2002301051B9 (en) Extended cDNAs for secreted proteins
AU2003262114B2 (en) cDNAs encoding secreted proteins
AU2003204659B2 (en) Extended cDNAs for secreted proteins
EP1903111A2 (fr) ADN étendus pour protéines secrétées
AU1049199A (en) Extended cdnas for secreted proteins
AU2003262217A1 (en) 5' ESTs and encoded human proteins
AU2006225329A1 (en) cDNAs encoding secreted proteins

Legal Events

Date Code Title Description
FZDE Dead